Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Prognostic and Predictive Biomarkers in Gliomas
Paulina Sledzinska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Analysis at the single-cell level indicates an important role of heterogeneous global DNA methylation status on the progression of lung adenocarcinoma
Quan-Fang Chen et al.
SCIENTIFIC REPORTS (2021)
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
Luca Jaromi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines
Victoria Sarne et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Epidrugs: targeting epigenetic marks in cancer treatment
Cristiana Libardi Miranda Furtado et al.
EPIGENETICS (2019)
Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma
Ju-Hong Yang et al.
BIOLOGICAL RESEARCH (2019)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neal I. Lindeman et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer
R. F. H. Walter et al.
PLOS ONE (2018)
Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood
Bao-hua Wang et al.
ONCOTARGET (2017)
Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer
Shunlin Liu et al.
ONCOTARGET (2017)
Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis
Baoli Hu et al.
THORACIC CANCER (2017)
Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer
R. Kandimalla et al.
ONCOGENESIS (2017)
A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA
Akira Ooki et al.
CLINICAL CANCER RESEARCH (2017)
WNT signaling - lung cancer is no exception
Judit Rapp et al.
RESPIRATORY RESEARCH (2017)
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
Yan-li Guo et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC)
Hongxiang Feng et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications
Antonello Di Paolo et al.
EPIGENOMICS (2016)
Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer
Lukas E. Dow et al.
CELL (2015)
RASSF tumor suppressor gene family: Biological functions and regulation
Natalia Volodko et al.
FEBS LETTERS (2014)
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
David J. Stewart
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis
Dong-Tao Shi et al.
TUMOR BIOLOGY (2014)
Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
Anastasia A. Ponomaryova et al.
LUNG CANCER (2013)
Dapper Homo log 1 Is a Novel Tumor Suppressor in Gastric Cancer through Inhibiting the Nuclear Factor-κB Signaling Pathway
Shiyan Wang et al.
MOLECULAR MEDICINE (2012)
Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity
Zhao-Qiu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer
Youwei Zhang et al.
CANCER LETTERS (2011)
Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
Jefferson Terry et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients
Lela Buckingham et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Downregulation of HDPR1 Is Associated With Poor Prognosis and Affects Expression Levels of p120-Catenin and beta-Catenin in Nonsmall Cell Lung Cancer
Zhi-Qiang Yang et al.
MOLECULAR CARCINOGENESIS (2010)
Dpr Acts as a Molecular Switch, Inhibiting Wnt Signaling when Unphosphorylated, but Promoting Wnt Signaling when Phosphorylated by Casein Kinase Iδ/ε
Evelyn Teran et al.
PLOS ONE (2009)
Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type β-catenin nuclear accumulation in lung tumorigenesis
R-C Tseng et al.
ONCOGENE (2008)
Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non-small cell lung cancer
Makoto Suzuki et al.
CLINICAL CANCER RESEARCH (2007)
Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer
M Suzuki et al.
CANCER (2006)
Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer
JS Kim et al.
CANCER RESEARCH (2006)
Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation
L Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Wnt signalling in lung development and diseases
JE Pongracz et al.
RESPIRATORY RESEARCH (2006)
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
K Koinuma et al.
ONCOGENE (2006)
Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability
L Thorstensen et al.
NEOPLASIA (2005)
APC mutations are infrequent but present in human lung cancer
H Ohgaki et al.
CANCER LETTERS (2004)
RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer
J Li et al.
NEOPLASIA (2003)
Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: A high-throughput tissue microarray and immunohistochemistry study
DF Tan et al.
HUMAN PATHOLOGY (2003)
Aberrant DNA methylation in lung cancer: Biological and clinical implications
S Zochbauer-Muller et al.
ONCOLOGIST (2002)
Share Paper
